Assessing outcomes of fat transfer for breast or chest wall reconstruction
Quantitative Assessment of Autologous Fat Transfer
This study is testing if using your own fat for breast or chest wall reconstruction can improve results and satisfaction for patients over time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Trial ID | NCT06343831 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to evaluate the effectiveness of autologous fat transfer (AFT) for breast or chest wall reconstruction by utilizing various imaging techniques. Participants will undergo standard 2D photographs, 3D surface scanning, ultrasound, and MRI to assess changes in the breast over time. Additionally, they will complete the BREAST-QTM questionnaire to measure patient satisfaction and quality of life. The study will compare imaging results to provide a comprehensive understanding of the outcomes associated with AFT.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are planning to undergo autologous fat transfer for breast or chest wall reconstruction.
Not a fit: Patients with active cancer, metastatic disease, or those unable to undergo MRI due to contraindications will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of patient outcomes and satisfaction following autologous fat transfer, leading to improved surgical techniques and patient care.
How similar studies have performed: While this study employs established imaging techniques, the specific combination and focus on patient-reported outcomes in the context of AFT is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Age of 18 years or older * Planned autologous fat transfer or fat grafting reconstruction of the breast or chest wall. * Able to provide written or electronic informed consent. * Able to undergo MRI. Exclusion Criteria: * Vulnerable subjects (children, prisoners, pregnant women). * Patients who have active cancer, metastatic disease, solid organ transplantation / immunosuppression, or autoimmune diseases. * Unable to undergo MRI (history of metal contraindication, claustrophobia)
Where this trial is running
Chicago, Illinois and 1 other locations
- The University of Chicago — Chicago, Illinois, United States (Recruiting)
- The University of Houston — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Summer Hanson, MD — University of Chicago
- Study coordinator: Summer Hanson, MD
- Email: sehanson@bsd.uchicago.edu
- Phone: 773-702-6302
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.